Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1994, Deerfield Management Company is based in New York City and manages over $15 billion in assets as of December 2024. The firm focuses on advancing healthcare through investment, intelligence, and philanthropy. With a team dedicated to supporting the healthcare sector, Deerfield has built a portfolio of over 200 companies.
Deerfield invests in the healthcare ecosystem, including biotech, medical devices, diagnostics, digital health, and healthcare services. They engage with companies at all stages, from Friends & Family rounds to IPOs, providing flexible funding models tailored to entrepreneurs' needs. Typical investments span various stages, including pre-seed, Series A, and growth equity.
Deerfield's portfolio features over 200 investments, including notable companies such as Ablexis, founded in May 2018, focusing on therapeutics; Actio Biosciences, established in May 2022, also in therapeutics; Acutus Medical, specializing in medical technologies since February 2016; AdaptHealth, operating in healthcare services since December 2017; and Adela, working in medical technologies since March 2021.
To pitch Deerfield Management, email your deck to karenh1@deerfield.com.
Yes, Deerfield often leads investment rounds, particularly in early-stage healthcare companies.
Deerfield is open to follow-on investments, supporting portfolio companies as they grow and require additional funding.
Deerfield Management currently manages over $15 billion in assets, allowing for significant investments across various stages of company development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.